NASDAQ · Biotechnology

FATE (FATE) Stock

$2.31 -0.43% NASDAQ: FATE Healthcare

Valuation

MetricValue
Price$2.31
Market Cap$269.25M
P/E Ratio-1.62
P/B Ratio1.05
P/S Ratio33.96
EPS (TTM)$-1.15
52-Week High$3.13
52-Week Low$0.91
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-65.70%
ROA-42.63%
ROCE-71.50%
Gross Margin-2100.00%
Operating Margin-2114.29%
Net Margin-20.57%
Debt/Equity0.43
Current Ratio5.81

Annual Financials (USD)

Metric20212022202320242025
Revenue$56.0M$96.0M$64.0M$14.0M$7.0M
Operating Profit$-217.0M$-308.0M$-191.0M$-210.0M$-148.0M
Net Profit$-212.0M$-282.0M$-161.0M$-186.0M$-136.0M
EPS$-2.24$-2.91$-1.64$-1.64$-1.15
Op Margin-388.6%-320.2%-299.9%-1542.6%-2222.4%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$921.0M$706.0M$506.0M$441.0M$319.0M
Total Liabilities$243.0M$222.0M$138.0M$122.0M$112.0M
Cash$134.0M$61.0M$42.0M$36.0M$47.0M
Borrowings$115.0M$109.0M$104.0M$85.0M$78.0M

Latest News

FATE Stock Jumps 6% As FDA Greenlights Moving Cell Therapy To Clinical Trials Stocktwits · Jul 9, 2026 Sector Update: Healthcare Stocks Softer Late Afternoon MT Newswires · Jul 9, 2026 Sector Update: Healthcare MT Newswires · Jul 9, 2026 Update: Fate Therapeutics Shares Rise After FDA Clears Investigational New Drug Application for FT839 MT Newswires · Jul 9, 2026 Fate Therapeutics Receives FDA Clearance of Investigational New Drug Application for FT839 Product Candidate GlobeNewswire · Jul 9, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-163.0M$-248.0M$-132.0M$-123.0M$-106.0M
Investing Cash Flow$-375.0M$131.0M$107.0M$11.0M$105.0M
Financing Cash Flow$41.0M$0$0$5.0M$5.0M
Net Cash Flow$-34.0M$-72.0M$-19.0M$-6.0M$11.0M
Free Cash Flow$-214.0M$-284.0M$-138.0M$-124.0M$-112.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA—
FCF Yield-50.40%
Quick Ratio5.85
Interest Coverage—
Return 1Y96.88%
Return 3Y-41.53%
Return 5Y-96.10%

Ownership

Insiders Held1.17%
Institutions Held73.03%
Institutions Float Held73.89%
Institutional HolderSharesReport Date
Redmile Group, LLC12,872,9462026-03-31
Blackrock Inc.10,068,6142026-03-31
Vanguard Capital Management LLC4,192,0632026-03-31
Vanguard Portfolio Management LLC4,134,5852026-03-31
Acadian Asset Management. LLC4,120,2002026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ABOS $2.27 -0.66% -1.17 $163.60M 0.00%
ALEC $1.52 +0.33% -1.58 $168.20M 0.00%
CRBP $9.11 +0.33% -1.95 $168.79M 0.00%
INO $1.04 +0.97% -2.73 $55.73M 0.00%
MOLNMolecular Partners AG $3.91 -2.25% -2.08 $146.67M 0.00%

About FATE

FATE is led by CEO Bahram Valamehr, employs 181 people, headquartered in US, publicly traded since 2013.

FATE stock trades at $2.31 with a market capitalization of $269.25M. The stock is valued at a price-to-earnings (P/E) ratio of -1.62, price-to-book of 1.05, price-to-sales of 33.96. Over the past 52 weeks the stock has ranged between $0.91 and $3.13, and currently trades 26.2% below its 52-week high.

On profitability, FATE generates a return on equity (ROE) of -65.70%, return on capital employed of -71.50%, an operating margin of -2114.29%, a net profit margin of -20.57%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides